News About: Pharm. Industry
KRPMA activates to take part in KPMA
The KPMA decided to provide more opportunities to the foreign invested company organization, KRPMA to take part in the administration of KPMA for development of domestic pharmaceutical industry in such a globalization...
Drug industry expedited to restructuring by Government this year.
According to "99 major project promotion plan" reported by the MOHW, the MOHW will induce the local drug industry autonomously to make restructuring so as to eliminate duplicate and a lavish investment and unreasonabl...
Shareholder's meeting of most listed drug firms scheduled on Mar. 12.
23 listed pharmaceutical companies (fiscal year ended at Dec. 31) excluding the firms in process of court arbitration made schedules for their shareholder's meeting on March 12 and 19. 18 companies including Dong-A on...
50 billion Won sales targeted in 1999 by GlaxoWellcome Korea.
GlaxoWellcome Korea (President: Kim Jin-ho) established the company management objective this year aiming at a base construction of business profit ensuing the previous year by intensifying the sales organization and ...
1998 Sales growth of leading drug makers slow.
The sales of leading pharmaceutical manufacturers last year went up slow at merely 4% level of its growth over the previous year, YK Newletter survey reported, which was attributed largely to the nationwide ec...
Discount after sales transaction to cut or eliminate.
So far the drug company has traditionally provided so-called "Discount after sales" to the customer, a sort of allowance payable at the end of year or some time after the sales transaction. Since such allowance has be...
Insurance reimbursement policy of imported drugs painful to foreign pharmaceutical firms.
The government approved the insurance reimbursement for imported drugs to be implemented from July 1 at far lower prices than the level in current practice, and therefore foreign pharmaceutical firms raised its proble...
Survey on top executives over pharmaceutical economy (1)
Survey on top executives over pharmaceutical economy (1) Pharmaceutical business recovery to predict from year after next.
YK Consultant surveyed "The pharmaceutical economic perspective this year and countermeasu...
Survey on top executives over pharmaceutical economy (1)
Survey on top executives over pharmaceutical economy (1) Pharmaceutical business recovery to predict from year after next.
YK Consultant surveyed "The pharmaceutical economic perspective this year and countermeasu...
Survey on top executives over pharmaceutical economy (2)
With regard to the changes in drug distribution channel even after the implementation of the medical/pharmacy separation system, 62.9% of respondents indicated to intensify more the wholesale transaction, 11.4% to rei...
